---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289379675.md"
description: "In Wednesday's after-market session, several healthcare stocks saw significant movement. Gainers included HeartSciences (+16.5%), Icon (+10.65%), and Processa Pharma (+10.6%). Conversely, losers featured BGM Group (-14.1%), Humacyte (-10.53%), and Valion Bio (-7.97%). The report highlights specific price changes and market capitalizations for these listed companies."
datetime: "2026-06-10T21:05:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289379675.md)
  - [en](https://longbridge.com/en/news/289379675.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289379675.md)
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **HeartSciences** (NASDAQ:HSCS) stock moved upwards by 16.5% to $2.19 during Wednesday's after-market session. The company's market cap stands at $5.9 million.
-   **Icon** (NASDAQ:ICLR) shares rose 10.65% to $160.0. The company's market cap stands at $11.5 billion.
-   **Processa Pharma** (NASDAQ:PCSA) stock moved upwards by 10.6% to $2.19. The company's market cap stands at $5.5 million.
-   **Aditxt** (NASDAQ:ADTX) stock increased by 7.56% to $0.02.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock increased by 6.25% to $1.87. The company's market cap stands at $6.9 million.
-   **Allarity Therapeutics** (NASDAQ:ALLR) stock increased by 6.04% to $1.58. The market value of their outstanding shares is at $25.6 million.

### Losers

-   **BGM Group** (NASDAQ:BGM) stock fell 14.1% to $0.37 during Wednesday's after-market session. The market value of their outstanding shares is at $68.2 million.
-   **Humacyte** (NASDAQ:HUMA) stock declined by 10.53% to $1.2. The market value of their outstanding shares is at $308.6 million.
-   **Valion Bio** (NASDAQ:VBIO) stock fell 7.97% to $0.73. The company's market cap stands at $2.3 million.
-   **Upstream Bio** (NASDAQ:UPB) stock decreased by 7.65% to $5.8. The market value of their outstanding shares is at $364.0 million.
-   **Azitra** (AMEX:AZTR) stock decreased by 7.46% to $0.22. The company's market cap stands at $3.4 million.
-   **Entrada Therapeutics** (NASDAQ:TRDA) shares fell 7.04% to $5.55. The market value of their outstanding shares is at $247.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [VBIO.US](https://longbridge.com/en/quote/VBIO.US.md)
- [HUMA.US](https://longbridge.com/en/quote/HUMA.US.md)
- [BGM.US](https://longbridge.com/en/quote/BGM.US.md)
- [PCSA.US](https://longbridge.com/en/quote/PCSA.US.md)
- [ICLR.US](https://longbridge.com/en/quote/ICLR.US.md)
- [HSCS.US](https://longbridge.com/en/quote/HSCS.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [ALLR.US](https://longbridge.com/en/quote/ALLR.US.md)
- [UPB.US](https://longbridge.com/en/quote/UPB.US.md)
- [AZTR.US](https://longbridge.com/en/quote/AZTR.US.md)
- [TRDA.US](https://longbridge.com/en/quote/TRDA.US.md)
- [HSCSW.US](https://longbridge.com/en/quote/HSCSW.US.md)
- [HUMAW.US](https://longbridge.com/en/quote/HUMAW.US.md)

## Related News & Research

- [Is ICON (ICLR) Using Buybacks And New Directors To Reset Trust After Control Weaknesses?](https://longbridge.com/en/news/289222629.md)
- [Humacyte's Bioengineered Blood Vessel Hits Primary Endpoint in Phase 3 Trial](https://longbridge.com/en/news/289379825.md)
- [Humacyte ATEV meets Phase 3 V012 primary endpoint; plans supplemental BLA filing H2 2026](https://longbridge.com/en/news/289374961.md)
- [Humacyte Enters Underwriting Agreement for 47.6M-Share Offering at $1.05, Nets ~$46.8M](https://longbridge.com/en/news/289513555.md)
- [H.C. Wainwright Sticks to Its Buy Rating for Shattuck Labs (STTK)](https://longbridge.com/en/news/289068921.md)